BioPharma Drive: Drug Pricing
JUNE 10, 2025
The abrupt termination of the 17 panelists guiding the CDC’s vaccine recommendations could yield a new committee more aligned with Robert F. Kennedy Jr.’s skeptical views, analysts warned.
Drugs.com
JUNE 10, 2025
TUESDAY, June 10, 2025 — U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has removed all 17 members of the expert panel that makes U.S. vaccine recommendations. Kennedy made the surprise announcement in an opinion piece.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
JUNE 10, 2025
Scientists in Japan have discovered that a natural compound found in a type of ginger called kencur can throw cancer cells into disarray by disrupting how they generate energy. While healthy cells use oxygen to make energy efficiently, cancer cells often rely on a backup method. This ginger-derived molecule doesn t attack that method directly it shuts down the cells' fat-making machinery instead, which surprisingly causes the cells to ramp up their backup system even more.
Drugs.com
JUNE 10, 2025
TUESDAY, June 10, 2025 — Blood tests can detect evidence of cancer three years earlier than the disease would otherwise be diagnosed, a new small-scale pilot study says. The test — called a multicancer early detection (MCED) test.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Science Daily: Pharmacology News
JUNE 10, 2025
Acetaminophen may be doing more than just dulling pain in your brain it could be stopping it before it even starts. Scientists at Hebrew University have discovered that a metabolite of the drug, AM404, blocks pain signals right at their source by shutting down specific sodium channels in pain-sensing nerves. This radically shifts our understanding of how this common medication works and opens a door to new, more targeted painkillers that might eliminate side effects like numbness or weakness.
BioPharma Drive: Drug Pricing
JUNE 10, 2025
The startup, which has raised more than $2 billion in funding to aid young biotechs with drug production, said its “capacity expansion has outpaced industry demand.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
BioPharma Drive: Drug Pricing
JUNE 10, 2025
Five months after selling a cancer drug to Lilly for up to $2.5 billion, Scorpion has debuted a successor company led by its former management team to chase “previously inaccessible” drug targets.
Drugs.com
JUNE 10, 2025
TUESDAY, June 10, 2025 — Out of concern, many parents might be spoiling their child’s best chance to avoid developing a food allergy, a new study says. Allergy experts recommend children at risk of food allergies start being introduced.
Chemical Biology and Drug Design
JUNE 10, 2025
In this study, the polysaccharides extracted from the residue of Corydalis yanhusuo were purified, its structure was characterized, and its antioxidant and anti-tumor activities in vitro were studied. The results showed that the purified polysaccharides of Corydalis yanhusuo have the potential as a natural antioxidant and anti-tumor agent. ABSTRACT This research extracted and purified polysaccharides from Corydalis yanhusuo residue.
Drugs.com
JUNE 10, 2025
TUESDAY, June 10, 2025 — The TikTok video shows a teenage girl in braces applying a series of 14 beauty products to her face, an arsenal that costs nearly $350 all told. It’s one of many such videos where girls share their beauty.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
addgene Blog
JUNE 10, 2025
These days, it hardly seems like we finish writing about one dual CRISPR-transposon system before another exciting new advance emerges! The programmability and targeting power of CRISPR combined with the large sequence capacity of transposons open whole new worlds to explore. The newest arrival on the scene is called evoCAST — an evolved CRISPR-associated transposase (CAST).
Drugs.com
JUNE 10, 2025
TUESDAY, June 10, 2025 — Emergency surgeries are gnawing away at U.S. health care spending, with racial disparities fueling the bill, a new study says. Emergency surgeries cost about 33% more than planned procedures, averaging $13,645 more.
Science Daily: Pharmacology News
JUNE 10, 2025
Some volcanoes erupt with little to no warning, posing serious risks to nearby communities and air traffic. A study of Alaska's Veniaminof volcano reveals how specific internal conditions like slow magma flow and warm chamber walls can create these so-called "stealthy eruptions.
Drugs.com
JUNE 10, 2025
TUESDAY, June 10, 2025 — A happy family life can help tweens get better sleep, a new study says. Kids are more likely to sleep longer if they have strong family relationships with highly engaged parents, according to research scheduled for.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Science Daily: Pharmacology News
JUNE 10, 2025
A prehistoric digestive time capsule has been unearthed in Australia: plant fossils found inside a sauropod dinosaur offer the first definitive glimpse into what these giant creatures actually ate. The remarkably preserved gut contents reveal that sauropods were massive, indiscriminate plant-eaters who swallowed leaves, conifer shoots, and even flowering plants without chewing relying on their gut microbes to break it all down.
Drug Patent Watch
JUNE 10, 2025
The Secret to Unlocking Affordable Medication: A Simple 3-Step Guide to Checking if Your Prescription is Tied Up in Patent Red Tape As the cost of prescription medication continues to skyrocket, it's more crucial than ever to understand the complex world of pharmaceutical patents. But do you know if the medication you're taking is protected by a patent?
Science Daily: Pharmacology News
JUNE 10, 2025
Astronomers using the James Webb Space Telescope have captured breathtakingly detailed images of two giant exoplanets orbiting a distant sun-like star. These observations revealed sand-like silicate clouds in one planet s atmosphere and an unexpected disk around another that may be forming moons something previously seen only in much younger systems.
Reprocell
JUNE 10, 2025
The Power of mRNA Reprogramming The emergence of mRNA reprogramming offers a precise, efficient, and xeno-free approach to generating induced pluripotent stem cells (iPSCs). These versatile cells hold immense potential for personalized medicine, disease modelling, and drug discovery. REPROCELL has led the way in mRNA reprogramming, in 2010 becoming the first company to commercialize mRNA-based reprogramming technologies.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Crucial Data Solutions
JUNE 10, 2025
The Post-Market Shift: From Sites to Data Streams Phase IV trials used to mean tracking long-term outcomes by continuing to. The post Modern Post-Market Trials Will Be Driven by RWD – Is Your EDC Ready? appeared first on Crucial Data Solutions.
Perficient: Drug Development
JUNE 10, 2025
With thousands of skilled strategists and technologists worldwide , Perficient harnesses a collaborative spirit that d elivers real results through the power of technology. We combine o ur deep industry expertis e with trusted partnerships alongside leading technology innovators to trans form some of the world’s biggest brands. Perficient’s vision is to be the place where great minds and great companies converge to boldly advance business.
RAND: Drug Policy and Trends
JUNE 10, 2025
The trade war has reshaped the U.S.-China economic relationship, with America's position weakening over time. While Washington retains meaningful leverage over Beijing, that influence is steadily diminishing as China reduces its vulnerabilities. Meanwhile, China's control over critical supply chains continues to deepen.
Drug Channels
JUNE 10, 2025
The 340B Drug Pricing Program has emerged as a growing source of profits for pharmacies and pharmacy benefit managers (PBMs). Drug Channels Institute’s latest exclusive analysis of the 2025 market reveals a highly concentrated market structure increasingly dominated by a handful of major players: About 32,000 pharmacy locations—nearly 60% of the entire U.S. pharmacy industry—function as contract pharmacies for the hospitals and federal grantees that participate in the 340B program.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Perficient: Drug Development
JUNE 10, 2025
In the push for more equitable and user-friendly experiences, three key concepts often arise: Accessibility, Inclusive Design, and Universal Design. While they share a common goal, ensuring usability for as many people as possible, they have distinct approaches and applications. So, what makes them different? Let’s break it down. Accessibility: Removing Barriers Accessibility is about making accommodations for people with disabilities so they can access and use physical spaces, digital platforms
RAND: Drug Policy and Trends
JUNE 10, 2025
The recent decision by the Kurdistan Workers' Party (PKK) to disarm and disband offers vital lessons for countries facing insurgencies. Turkey's mixed approach highlights the importance of comprehensive strategies to foster sustainable peace and encourage armed groups to transition into political participation.
Drugs.com
JUNE 10, 2025
TUESDAY, June 10, 2025 — Statins are a gold-standard treatment for lowering cholesterol, but a new study shows the inexpensive drugs could provide another life-saving service. Patients with sepsis appear to have a lower risk of dying if.
RAND: Drug Policy and Trends
JUNE 10, 2025
If AI can indeed make scientific discoveries, that would not only have practical impacts for society but would also provide evidence that we've achieved true digital intelligence. But reaching expert consensus on what counts as a scientific discovery by an AI may prove more elusive than expected.
Drugs.com
JUNE 10, 2025
TUESDAY, June 10, 2025 — A 2010 U.S. Supreme Court ruling may have led to more gun deaths of children and teens in states that enacted more lenient gun laws afterward, new research suggests. The study — published June 9 in JAMA.
ProRelix Research
JUNE 10, 2025
As the world adapts to a post-pandemic reality, a new COVID-19 variant emerging in 2025 has sparked renewed concern across global health systems. Despite major advances in vaccination, therapeutics, and […] The post The New COVID Variant in 2025: Should We Be Worried? appeared first on ProRelix Research.
FDA Law Blog: Biosimilars
JUNE 10, 2025
By Larry K. Houck — Special Surveillance List of Chemicals, Products, Materials and Equipment Updated A “laboratory supply” is any List I or List II chemical, or any chemical, substance, or other item on a special surveillance list published by the Attorney General (delegated to the Drug Enforcement Administration (“DEA”)) of chemicals, products, materials, or equipment used in the illicit manufacture of controlled substances and listed chemicals. 21 U.S.C. § 842(a).
Science Daily: Pharmacology News
JUNE 10, 2025
A violent solar eruption on May 31 launched a coronal mass ejection (CME) hurtling toward Earth, triggering a rare G4-level geomagnetic storm alert. Captured in real-time by U.S. Naval Research Laboratory instruments, this cosmic blast has the potential to disrupt satellites, communications, and military systems.
Drugs.com
JUNE 10, 2025
TUESDAY, June 10, 2025 — BowFlex, a fitness equipment brand, is recalling more than 3.8 million adjustable dumbbells because their weight plates can fall off and hurt users. The recall follows more than 100 reports of injuries, including.
Expert insights. Personalized for you.
285 
Let's personalize your content